Induction of cancer cell migration by epidermal growth factor is initiated by specific phosphorylation of tyrosine 1248 of c‐erbB‐2 receptor via epidermal growth factor receptor-Reference-Cited by-同舟云学术

Induction of cancer cell migration by epidermal growth factor is initiated by specific phosphorylation of tyrosine 1248 of c‐erbB‐2 receptor via epidermal growth factor receptor

Published:2002-09-19 Issue:13 Volume:16 Page:1-21
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Dittmar Thomas¹,Husemann Anja²,Schewe Yvonne¹,Nofer Jerzy‐Roch²,Niggemann Bernd¹,Zänker Kurt S.¹,Brandt Burkhard H.²

Affiliation:

1. Institute of ImmunologyUniversity of Witten/ Herdecke Stockumer Str. 10 58448 Witten Germany

2. Institute of Clinical Chemistry and Laboratory MedicineUniversity of Münster Albert‐Schweitzer‐Str. 33 48129 Münster Germany

Funder

Fritz-Bender-Stiftung

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.02-0096fje

Reference30 articles.

1. The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions

2. NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer

3. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

4. Binding specificities and affinities ofegfdomains for ErbB receptors

5. Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Role of Nrf2, HER2, and ALDH in Cancer Stem Cells: A Narrative Review;The Journal of Membrane Biology;2024-02-14

2. Dysregulation of phospholipase C signaling pathway in breast and colorectal cancer: Association with progression and prognosis;Phospholipases in Physiology and Pathology;2023

3. Phospholipase C isoenzyme and its role in breast cancer: A novel therapeutic approach;Phospholipases in Physiology and Pathology;2023

4. A multi-layered hybrid model for cancer cell invasion;Medical & Biological Engineering & Computing;2022-02-28

5. Recent advances in understanding the molecular role of phosphoinositide-specific phospholipase C gamma 1 as an emerging onco-driver and novel therapeutic target in human carcinogenesis;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2021-12